Recent Finacing
Recent Raise
Inimmune develops novel vaccine adjuvants and immune therapies targeting oncology, allergy, and emerging and antibiotic‑resistant infections, advancing multiple late‑stage preclinical candidates toward Phase I human trials in Missoula, Montana.
